Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shields

Showing results (191-200 of 413) with videos related to

Pageof 42
Sort By:
Antimicrobial Agents and Chemotherapy|December 23, 2025
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremiaSunish Shah, Lloyd G Clarke, Bonnie A Falcione, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 15, 2010
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipientH-Y Sun, R K Shields, T V Cacciarelli, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam ResistanceRyan K Shields, M Hong Nguyen, Binghua Hao, et al.
BMC Medical Education|September 14, 2023
Healthcare educational debt in the united states: unequal economic impact within interprofessional team membersRichard K Shields, Manish Suneja, Bridget E Shields, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 22, 2011
High dose compressive loads attenuate bone mineral loss in humans with spinal cord injuryS Dudley-Javoroski, P K Saha, G Liang, et al.
Agents and Actions. Supplements|January 1, 1991
Novel inhibitors of pulmonary eosinophil accumulationI M Richards, S K Shields, M J Bienkowski, et al.
Physical Therapy|March 1, 1995
Reliability, validity, and responsiveness of functional tests in patients with total joint replacementR K Shields, L J Enloe, R E Evans, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosisA Baheerathan, W J Brownlee, D T Chard, et al.
Journal of Global Antimicrobial Resistance|April 8, 2024
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centresRyan K Shields, Emre Yücel, Vladimir Turzhitsky, et al.
Open Forum Infectious Diseases|January 15, 2021
Discordance Among Antibiotic Prescription Guidelines Reflects a Lack of Clear Best PracticesLauren M Rost, M Hong Nguyen, Cornelius J Clancy, et al.
Pageof 42

Showing results (191-200 of 413) with videos related to

Sort By:
Pageof 42
Antimicrobial Agents and Chemotherapy|December 23, 2025
Incidence and factors associated with rapid blood culture sterilization among patients receiving ertapenem combination therapy for MSSA bacteremiaSunish Shah, Lloyd G Clarke, Bonnie A Falcione, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 15, 2010
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipientH-Y Sun, R K Shields, T V Cacciarelli, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Colistin Does Not Potentiate Ceftazidime-Avibactam Killing of Carbapenem-Resistant Enterobacteriaceae In Vitro or Suppress Emergence of Ceftazidime-Avibactam ResistanceRyan K Shields, M Hong Nguyen, Binghua Hao, et al.
BMC Medical Education|September 14, 2023
Healthcare educational debt in the united states: unequal economic impact within interprofessional team membersRichard K Shields, Manish Suneja, Bridget E Shields, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|December 22, 2011
High dose compressive loads attenuate bone mineral loss in humans with spinal cord injuryS Dudley-Javoroski, P K Saha, G Liang, et al.
Agents and Actions. Supplements|January 1, 1991
Novel inhibitors of pulmonary eosinophil accumulationI M Richards, S K Shields, M J Bienkowski, et al.
Physical Therapy|March 1, 1995
Reliability, validity, and responsiveness of functional tests in patients with total joint replacementR K Shields, L J Enloe, R E Evans, et al.
Multiple Sclerosis and Related Disorders|March 12, 2017
Antecedent anti-NMDA receptor encephalitis in two patients with multiple sclerosisA Baheerathan, W J Brownlee, D T Chard, et al.
Journal of Global Antimicrobial Resistance|April 8, 2024
Real-world evaluation of imipenem/cilastatin/relebactam across US medical centresRyan K Shields, Emre Yücel, Vladimir Turzhitsky, et al.
Open Forum Infectious Diseases|January 15, 2021
Discordance Among Antibiotic Prescription Guidelines Reflects a Lack of Clear Best PracticesLauren M Rost, M Hong Nguyen, Cornelius J Clancy, et al.
Pageof 42